HelmholtzZentrum munich
WCMC

Connecting genetic risk to disease endpoints through the human blood plasma proteome

ONLINE SUPPLEMENTARY INFORMATION

Ideogram
Proteome annotation
Locus annotations

Locus 90

Top associations per target

Target cis/​trans Study SNP SNP location Maj/​min allele MAF N βinv seinv Pinv fclog Plog Praw
CYTD cis Discovery rs6138152 20:23,850,130 A/G 0.20 997 0.718 0.050 1.8×10-42 1.410 4.7×10-43 8.7×10-39
CYTD cis Replication rs6138150 20:23,847,009 A/G 0.14 337 0.480 0.084 2.5×10-8 1.360 6.8×10-8 1.6×10-4

 

Regional association plots

 

Boxplots and histograms for top associations

Cystatin-D (CYTD)

inverse-normalized probe levels log2 transformed probe levels raw probe levels
Discovery study
Replication study

Cystatin-D (CYTD)

Target (abbrv.) CYTD
Target (full name) Cystatin-D
Somalogic ID (Sequence ID) SL008382 (3803-10_2)
Entrez Gene Symbol CST5
UniProt ID P28325
UniProt Comment
  • Cysteine proteinase inhibitor that possibly plays a protective role against proteinases present in the oral cavity. The order of preference for inhibition is cathepsin S > cathepsin H > cathepsin L > cathepsin B.
Wiki Pathways
  • Endochondral Ossification

All locus annotations are based on the sentinel SNP (rs6138152) and 42 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)

Linked genes

Genes hit or close-by
Potentially regulated genes
eQTL genes

 

Results from other genome-wide association studies

Trait P Study Source
Cystatin C in serum 1.5×10-10 20383146 (PMID) GRASP2 nonQTL
cg02882813 (chr20:23860054) 3×10-10 10.1101/033084 (DOI) BIOS QTL cis-meQTLs
Gene expression of RAB11FIP5 in peripheral blood monocytes 6.3×10-8 20502693 (PMID) GRASP2 eQTL
Gene expression of CST3 in blood 2×10-7 21829388 (PMID) GRASP2 eQTL
Gene expression of EPHB3 in peripheral blood monocytes 2.6×10-6 20502693 (PMID) GRASP2 eQTL
Response to anti-TNF treatment for rheumatoid arthritis (change in Disease Activity Score (DAS28)) 2.8×10-6 18615156 (PMID) GRASP2 nonQTL
Response to TNF antagonist treatment 3×10-6 18615156 (PMID) GWAS Catalog via SNiPA
Gene expression of TC2N in peripheral blood monocytes 4×10-6 20502693 (PMID) GRASP2 eQTL
Autism 4.8×10-4 20663923 (PMID) GRASP2 nonQTL